Articles tagged with Clinical Trials
A JAMA study found that hemoglobin-based blood substitutes are associated with a 30% increased risk of death and a 2.7 times increased risk of heart attack in patients. The researchers argue for stricter regulations on the development of these products to prevent future safety concerns.
A systematic review published in PLoS Medicine identified a need for standardized measurements in pediatric clinical trials due to the lack of parent and child involvement in selecting outcomes. The study found that only three groups asked parents about the outcomes, while none involved children directly.
A 5-year study found that one or two rounds of mass treatment with azithromycin can eliminate trachoma infection in communities with moderate levels of infection. The trial showed a significant reduction in trachoma prevalence from 9.5% to 0.1% after just two years.
A breath monitoring device helps prevent the emergence of drug-resistant strains of HIV by tracking medication adherence in high-risk individuals. The device records patients' breath tests and provides real-time feedback to doctors.
The 'GeparQuattro' trial shows that combining anthracycline and taxane chemotherapy with trastuzumab improves HER2 breast cancer response rates to 41.3%, compared to 19.5% without trastuzumab. The regimen also minimizes cardiac toxicity, making it a promising treatment option.
A study found that aromatase inhibitors (AIs) do not increase the risk of heart problems in women who take them, contrary to previous fears. The research suggests AIs are superior to tamoxifen in reducing breast cancer recurrence and do not significantly worsen cardiovascular health.
A study suggests that the sponsor of rofecoxib, Merck, misrepresented the drug's safety profile in clinical trials involving patients with cognitive impairment. The analysis found a significant increase in mortality among rofecoxib patients compared to placebo patients, which was not reported by the sponsor.
The Michael J. Fox Foundation has awarded $5.6 million for a Phase 2 clinical trial investigating the potential of inosine to slow or stop Parkinson's disease progression. The study will determine the safety of using inosine to raise urate levels and assess optimal dosage for therapeutic effect.
The article addresses the importance of sharing data in clinical trials for heart studies, including situations where interim data should be shared with operational study personnel and sponsors. The authors emphasize the need for caution and careful consideration before releasing interim data, particularly when it comes to trial credib...
A randomized pilot trial found that lowering blood pressure to below 140 mm Hg reduced haematoma growth in patients with spontaneous intracerebral haemorrhage. The treatment also showed no significant adverse effects on clinical outcomes.
A literature review found no clear evidence of benefit or harm from increased water intake in healthy individuals. However, studies suggest that people with certain diseases and athletes may benefit from increased fluid intake. No single study indicates a need to drink the recommended '8x8' amount of water daily.
A study published in the Journal of General Internal Medicine found that disclosing a researcher's financial interests does not deter clinical trial participants, unless it involves ownership of equity. Patients rated financial disclosures as less important than risks and benefits when making their decisions.
Research shows that individuals who are anxious about appearing prejudiced may avoid interactions with people of different races due to fear of social disapproval. A study by Jennifer Richeson and Sophie Trawalter found that white participants focused on neutral black faces for longer periods than white faces, suggesting a cognitive bi...
A large randomized study found that angioplasty and stenting offer no benefit over medical therapy for patients with renal artery stenosis. After one year of follow-up, there were no differences in kidney function, blood pressure control, or major cardiovascular illness rates.
Recruitment of pediatric cancer patients into clinical trials is challenging due to age-specific barriers. The article emphasizes the need for more research and international cooperation to improve trial participation, particularly among young people.
A study examined 75 group-randomized oncology trials and found a substantial number of problems with the trials. Many relied on analyses that ignored group randomization altogether, raising concerns about type I errors. In contrast, HPV-based screening was found to be more accurate in detecting cervical precancerous lesions than cytology.
A review of 75 group-randomized cancer trials found that fewer than half used appropriate statistical methods to analyze results. The studies' flawed designs may have led to incorrect conclusions about intervention effectiveness.
A recent study analyzed data from over 216,000 patients in completed phase 3 randomized clinical trials. The results showed that new cancer treatments were found to be slightly superior to standard treatments in terms of patient outcomes such as survival.
A study found that hospitals participating in clinical trials have better quality of care, lower mortality rates, and improved processes for treating acute coronary syndrome. Patients treated at these hospitals had significantly better outcomes compared to those treated at non-participating hospitals.
Researchers found that tumour relapse rates were similar between lower dose regimens (50Gy, 41.6Gy, 39Gy) and the standard schedule. Both photographic and patient self-assessments suggested lower late adverse effects after these lower dose regimens.
Developing nations offer a ready supply of patients, large potential markets, and reduced competition for clinical trial sites. Companies conduct trials primarily in cities due to the presence of doctors, staff, and equipment similar to those found in Western conditions.
A study published in the American Journal of Preventive Medicine found that after-school programs increased moderate-to-vigorous physical activity among middle school girls by 80 calories a week. The intervention also reduced sedentary behavior by 8.2 minutes per day.
The ABSORB clinical trial demonstrated no stent thrombosis and a low rate of major adverse cardiac events (MACE) in patients with coronary artery disease. The bioabsorbable everolimus eluting stent was shown to be safe and effective, with successful deployment and high device success rates.
Scientists at MGH are exploring a potential cure for type 1 diabetes through a Phase I clinical trial. The trial uses the BCG vaccine, which has shown promising results in mouse models of autoimmune diabetes.
A study found that monthly personal contact with a counselor reduced weight regain by 3.3 lbs compared to self-directed programs, while interactive technology-based interventions showed similar results. More than 70% of participants maintained at least 8.8 lbs of weight loss.
A randomized clinical trial found that postoperative chemotherapy does not improve survival in patients with localized gastric cancer. Despite promising results in advanced gastric cancer, the combination of cisplatin, epirubicin, and other chemotherapies did not show significant benefits.
Researchers from the US and China have confirmed the effectiveness of a simple treatment for amblyopia in laboratory and clinical trials. The treatment, which involves training on a visual task, has shown promising results in improving vision and challenging traditional theories about critical periods.
An open-source clinical trial data-management system could save money and empower researchers in resource-poor settings. The system would eliminate the need for expensive database software systems, making high-standard research more accessible.
A new international study has found that increasing the intensity of chemotherapy can reduce mortality rates for children with severe Langerhans cell histiocytosis (LCH) by up to 20 percent. The study, which involved 193 pre-identified patients, demonstrated a statistically significant improvement in prognosis and survival rates.
A multicenter trial found that uterine artery embolization (UAE) is a viable alternative to hysterectomy for women with symptomatic fibroids. After two years, patients who underwent UAE reported health-related quality of life equal to those who had undergone hysterectomy.
A recent study published in The Lancet Neurology found that alteplase treatment can improve clinical outcomes in stroke patients even when administered outside the conventional 3-hour window. The researchers identified patients with an ischaemic penumbra and showed significant benefits in tissue reperfusion and reduced infarct growth.
The Argus II is the second-generation electronic retinal implant designed for treating blindness caused by Retinitis Pigmentosa. It consists of an array of 60 electrodes attached to the retina, conducting information from an external camera to provide rudimentary sight to implanted subjects.
A recent study found that a small proportion of individuals with hypertension eat diets aligned with government guidelines, while many others consume unhealthy patterns. The Dietary Approaches to Stop Hypertension (DASH) trial showed that a balanced diet high in fruits and vegetables can significantly lower blood pressure.
A recent study found a significant association between the combination of aprotinin and angiotensin-converting enzyme (ACE) inhibitors during off-pump cardiac surgery and postoperative renal dysfunction. The study, published in The Lancet, analyzed data from over 9,700 patients undergoing cardiac surgery between 2000 and 2007.
The NHLBI has stopped intensive blood glucose lowering treatment in a clinical trial of adults with type 2 diabetes, citing increased risk of death compared to standard treatment. Participants will now receive the less-intensive standard treatment.
Patients with moderate to severe plaque psoriasis receiving REMICADE experienced significant skin clearance improvements across four body regions, including head, trunk, and extremities. At week 10, 71-79% of patients achieved a PASI 75 improvement, with even greater success at 39-52% achieving a PASI 90 response.
Scientists query FDA about updating requirements for drug approval, citing limitations of current endpoints and methods. Researchers suggest alternative endpoints using new ophthalmic technologies like optical coherence tomography.
Researchers are exploring optimal dosage and timing for stem cell therapy in adults with strokes and newborns with ischemic injuries. Pilot studies indicate a 25% improvement in recovery, leading to plans for clinical trials within two years.
The use of clinical trials to inform Medicare coverage decisions disproportionately affects older women with comorbid conditions, differing significantly from the target population. This disparity highlights the need for more representative trial populations to ensure better value and improved outcomes for Medicare beneficiaries.
A candidate malaria vaccine showed strong immune responses in a small clinical trial conducted in Mali, where it was tested on 40 adults and is now being expanded to 400 children. The trial's promising results could provide new hope for fighting the disease that claims over 1 million lives annually.
A series of commentaries in Human Gene Therapy explores key controversies surrounding patient recruitment and trial management in gene therapy trials. The authors discuss the challenges of patients comprehending lengthy and technical study descriptions and consent forms, and propose innovative strategies for improving informed consent.
Using modified-release prednisone significantly reduces morning stiffness duration in RA patients by adapting to circadian rhythms. The new formulation has a higher mean relative change of -22.7% and reduced morning stiffness time by 44 minutes compared to standard prednisone.
A recent study by Children's Hospital of Pittsburgh found that adolescents and young adults with cancer are less likely to be enrolled in clinical trials for cutting-edge treatments. This can lead to lower survival rates compared to younger children, who have seen significant improvements in cure rates over the past 30 years.
A new questionnaire tool was developed to assess the informed consent process in clinical trials. The tool aimed to educate potential participants on the risks and benefits of taking part in research. However, the results showed that the tool did not improve informed consent in this experiment. Despite this, the study's findings provid...
A new protocol combining daily spontaneous awakening trials with spontaneous breathing trials results in better outcomes for mechanically ventilated patients, including shorter ventilation periods and earlier discharge. The study found that this approach improved clinical outcomes without increasing adverse events.
Researchers found that sirolimus reduced angiomyolipoma size by nearly 50% in TSC and LAM patients. Lung function also improved in LAM patients, with a 10-15% increase in expiratory air flow.
Researchers have developed a new method for presenting clinical trial survival data that includes all participants, overcoming the limitations of traditional Kaplan-Meier plots. This new approach provides a more accurate representation of treatment effects, enabling physicians and patients to better understand clinical trial results.
A recent study found that patients with severe COPD who received salmeterol-fluticasone (SFC) therapy had lower mortality rates compared to those treated with tiotropium. Additionally, SFC treatment was associated with better health status and fewer patient withdrawals.
Researchers found that anastomotic leakage rates were similar between patients with and without preoperative mechanical bowel preparation. However, patients who had mechanical bowel prep had fewer abscesses after anastomotic leakage. The authors advise abandoning mechanical bowel preparation due to potential drawbacks.
Stroke patients with mild to moderate impairments experience substantial improvement in upper limb function after just 2 weeks of constraint-induced movement therapy (CIMT). The effects are retained for up to 24 months, with significant improvements in quality of life, social participation, and activities of daily living.
A peptide vaccine for leukemia improved event-free survival by 8.7 months compared to non-responders, with 36% of responders experiencing complete cytogenetic remission. The vaccine targets cancer cells and induces a specific immune response in patients with HLA-A2
Results from two Phase I trials demonstrate clinical activity of ZOLINZA (vorinostat) combined with bortezomib in patients with relapsed and/or refractory multiple myeloma. The combination treatment showed partial or minimal responses in 48% of evaluable patients, suggesting potential for further evaluation in randomized clinical trials.
A UTSouthwestern urologist has used botulinum toxin A (Botox) injections to treat involuntary bladder contractions in quadriplegic patients. The treatment has shown promising results, enabling patients to regain control of their bladders and improve their quality of life.
Stereo mammography has been shown to reduce false positives by 49% compared to standard digital mammography, potentially cutting the number of women recalled for additional tests. The technology produces three-dimensional views of breast tissue, allowing radiologists to better interpret images and detect cancer earlier.
A clinical model predicting hip fracture risk in postmenopausal women was developed based on 11 clinical factors. The model was validated using data from the Women's Health Initiative and showed accuracy in stratifying risk among various ethnic backgrounds.
Multicenter trials show CT angiography highly accurate in detecting coronary artery disease with sensitivity of 85% and specificity of 90%. The noninvasive exam was equal in accuracy to invasive angiography in identifying patients to be referred for angioplasty or bypass surgery.
LymphoStat-B achieved a sustained improvement in disease activity across multiple clinical measures and decreased the frequency of disease flares over time. The study also showed that LymphoStat-B was well-tolerated through 2.5 years on treatment, with comparable incidence rates of adverse events to placebo.
The Phase 2b trial shows that Albuferon significantly reduces missed work days and improves health-related quality of life compared to peginterferon alfa-2a. Patients in the Albuferon treatment groups reported fewer days of missed work and less impairment of physical and mental health.
The Phase 2b study demonstrated that Albuferon achieved at least comparable efficacy and safety to peginterferon alfa-2a with a dosing regimen requiring half as many injections. Additionally, Albuferon showed less impairment of health-related quality of life on treatment.
Dr. Paul K. Whelton has been awarded the American Heart Association's Population Research Prize for his pioneering work in documenting the burden of cardiovascular diseases. His research has provided vital data on hypertension and its impact on populations worldwide.